GlaxoSmithKline Pharmaceuticals share news and announcements
NSE: GLAXOBSE: 500660Pharmaceuticals & BiotechnologyMid Cap
Formerly Glaxo (India)
Last close ₹2,404.70down ₹29.00 (1.19%)BSE ₹2,404.80
Share price at the NSE close on 23 Oct 2026. Previous close ₹2,433.70.
52-week range of traded prices to 23 Oct 2026
₹2,088.10Low, 12 Jun 2026₹3,120.70High, 28 Aug 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹40,737 Cr221st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 3 Aug 2026
- 38.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 13 May 2026
- 18.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.37%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 3 Aug 2026
- 50.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 3 Aug 2026
- 56.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 13 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 56,17458.6% delivered
GlaxoSmithKline Pharmaceuticals share news and announcements
721 announcements, routine notices left out, newest first. Page 14 of 15.
Nov 2010
2 Nov · Management
Boards of Directors at its Meeting held on October 28, 2010 have appointed Mr Simon Hardford as Non-retiring, Non-Executive Director and Mr. P V Bhide as Non-Executive Independent Director, both with effect from October 28, 2010.
Oct 2010
28 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2010 as follows: Net Sales of Rs. 58198 lacs for quarter ending on 30-SEP-2010 against Rs. 51181 lacs for the quarter ending on 30-SEP-2009. Net Profit / (Loss) of Rs. 15781 lacs for the quarter ending on 30-SEP-2010 against Rs. 14108 lacs for the quarter ending on 30-SEP-2009.12 Oct · Board meeting
To Consider amongst other things, approval of unaudited financial results for the quarter ended September 30, 2010.
Jul 2010
26 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 49793 lacs for quarter ending on 30-JUN-2010 against Rs. 45741 lacs for the quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 12899 lacs for the quarter ending on 30-JUN-2010 against Rs. 12435 lacs for the quarter ending on 30-JUN-2009.8 Jul · Board meeting
Interalia, to consider amongst other things, approval of unaudited financial results for the 2nd Quarter April-June 2010 & Half-year ended June 30, 2010.
May 2010
5 May · Management
As on the Board Meeting held on April 27, 2010, Mr. A . M. Nimbalkar has resigned as a Director of the Company with immediate effect.
Apr 2010
28 Apr · Meeting
Minutes of the Annual General Meeting of the members of the Company held on March 25, 2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Apr · Results
Standalone Results for the quarter ended on 31-MAR-2010 as follows: Net Sales of Rs. 54110 lacs for quarter ending on 31-MAR-2010 against Rs. 45715 lacs for the quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 16119 lacs for the quarter ending on 31-MAR-2010 against Rs. 14327 lacs for the quarter ending on 31-MAR-2009.20 Apr · Board meeting
To consider amongst other things, approval of unaudited financial results for the quarter ended March 31, 2010.
Mar 2010
26 Mar · Meeting
Members at the Annual General Meeting (AGM) of the Company held on March 25, 2010, inter alia, have accorded to the following: (1) Approval of Audited Annual Accounts for the year ended December 31, 2009 and the Report of Auditors and Directors thereon, (2) Approval of the declaration of Dividend of Rs. 30/- per Equity Share, (3) Re-appointment of Mr. R. R. Bajaaj, Mr. M. B. Kapadia & Mr. R. C. Sequeira as Directors of the Company liable to retire by rotation, (4) Re-appointment of M/s. Price Waterhouse & Co., as Statutory Auditors of the Company, (5) Appointment of Mr. A. M. Nimbalkar who was an Additional Director, as an Independent Director of the Company, (6) Amendment of Articles of Association of the Company in order to increase the strength of the Board of Directors from twelve to fifteen.12 Mar · Meeting
Notice of the Annual General Meeting of the members to be held on March 25, 2010. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.
Feb 2010
15 Feb · Corporate action
Register of Members and the share transfer Books of the Company will be closed from March 12, 2010 to March 25, 2010 (both days inclusive) for the purpose of payment of Dividend. Further, the dividend will be payable on or after March 25, 2010.15 Feb · Updates
Details of the financial results for the year ended December 31, 2009 pursuant to clause 20 of the Listing Agreement. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Feb · Dividend
At the meeting of the Board of Directors of the Company held on February 15, 2010 the Directors have recommended the payment of Dividend of Rs.30/- per equity share for the year ended December 31, 2009.15 Feb · Results
Standalone Results for the year ended on 31-DEC-2009 as follows: Net Sales of Rs. 187077 lacs for year ending on 31-DEC-2009 against Rs. 166041 lacs for the year ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 51229 lacs for the year ending on 31-DEC-2009 against Rs. 57657 lacs for the year ending on 31-DEC-2008.15 Feb · Results
Standalone Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 44440 lacs for quarter ending on 31-DEC-2009 against Rs. 36845 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 10359 lacs for the quarter ending on 31-DEC-2009 against Rs. 20847 lacs for the quarter ending on 31-DEC-2008.15 Feb · Results
Consolidated Results for the year ended on 31-DEC-2009 as follows: Net Sales of Rs. 190777 lacs for year ending on 31-DEC-2009 against Rs. 169341 lacs for the year ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 50786 lacs for the year ending on 31-DEC-2009 against Rs. 59109 lacs for the year ending on 31-DEC-2008.3 Feb · Board meeting
Inter-alia, to consider amongst other things, approval of audited financial results for the year ended December 31, 2009 and to recommend dividend, if any, on the equity shares of the Company.
Jan 2010
5 Jan · Results
The audited results for the year ended 31st December 2009 are expected to be approved by our Board of Directors before the end of March 2010 i.e. within a period of three months from the close of the accounting year and as such, we would be announcing the audited financial results within a period of three months of the close of the accounting year. We would therefore like to advice you that as permitted under Clause 41 of the Listing Agreement, we will not be publishing the unaudited financial results for the quarter ended 31st December 2009
Oct 2009
30 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 51181 lacs for quarter ending on 30-SEP-2009 against Rs. 45695 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 14108 lacs for the quarter ending on 30-SEP-2009 against Rs. 13197 lacs for the quarter ending on 30-SEP-2008.15 Oct · Board meeting
Interalia, to consider amongst other things, approval of unaudited financial results for the 3rd quarter June-September 2009.
Sep 2009
3 Sep · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter and half year ended June 30,2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
29 Jul · Management
Following changes in the Directorate with effect from July 27, 2009: 1) Mr. D. Sundaram has been appointed as an Independent Non-Executive Director in the casual vacancy caused by the resignation of Dr. Mark Reilly. 2) Mr. Ajit Nimbalkar has been appointed as an Additional Independent Non-Executive Director. 3) Mr. Peter Bains has resigned as a Director of the Company.27 Jul · Results
Standalone Results for the half year ended on 30-JUN-2009 as follows: Net Sales of Rs. 91456 lacs for half year ending on 30-JUN-2009 against Rs. 83501 lacs for the half year ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 26762 lacs for the half year ending on 30-JUN-2009 against Rs. 23613 lacs for the half year ending on 30-JUN-2008.27 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 45741 lacs for quarter ending on 30-JUN-2009 against Rs. 41690 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 12435 lacs for the quarter ending on 30-JUN-2009 against Rs. 11486 lacs for the quarter ending on 30-JUN-2008.15 Jul · Board meeting
Interalia, to consider amongst other things, approval of unaudited financial results for the 2nd Quarter April-June 2009 & Half year ended June 30, 2009.
May 2009
27 May · Meeting
Minutes of the Annual General Meeting of the members of the Company held on April 02, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 May · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended March 31, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2009
28 Apr · Results
Standalone Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 45715 lacs for quarter ending on 31-MAR-2009 against Rs. 41811 lacs for the quarter ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 14327 lacs for the quarter ending on 31-MAR-2009 against Rs. 12127 lacs for the quarter ending on 31-MAR-2008.13 Apr · Board meeting
To consider amongst other things, approval of unaudited financial results for the quarter ended 31st March 2009
Feb 2009
18 Feb · Updates
Details of the financial results for the year ended December 31, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Feb · Corporate action
Company has announced a Book Closure from March 20, 2009 to April 02, 2009 for the purpose of payment of Dividend. The dividend will be payable on or after April 02, 2009.18 Feb · Dividend
At the meeting of the Board of Directors held on February 18, 2009 the directors have recommended the payment of a Dividend of Rs. 22/- per equity share for the year ended December 31, 2008. The Directors are also pleased to recommend a special additional Dividend of Rs. 18/- per equity share.18 Feb · Results
Standalone Results for the year ended on 31-DEC-2008 as follows: Net Sales of Rs. 166041 lacs for year ending on 31-DEC-2008 against Rs. 157714 lacs for the year ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 57657 lacs for the year ending on 31-DEC-2008 against Rs. 53766 lacs for the year ending on 31-DEC-2007.18 Feb · Results
Standalone Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 36845 lacs for quarter ending on 31-DEC-2008 against Rs. 33927 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 20847 lacs for the quarter ending on 31-DEC-2008 against Rs. 8090 lacs for the quarter ending on 31-DEC-2007.18 Feb · Results
Consolidated Results for the year ended on 31-DEC-2008 as follows: Net Sales of Rs. 169341 lacs for year ending on 31-DEC-2008 against Rs. 160820 lacs for the year ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 59109 lacs for the year ending on 31-DEC-2008 against Rs. 54755 lacs for the year ending on 31-DEC-2007.11 Feb · Board meeting
To consider, amongst other things, approval of the audited financial results for the year ended December 31, 2008 and to recommend dividend, if any, on the equity shares of the Company.
Jan 2009
5 Jan · Results
"The audited results for the year ended 31st December 2008 are expected to be approved by our Board of Directors before the end of March 2009 i.e. within a period of three months from the close of the accounting year and as such, we would be announcing the audited financial results within a period of three months of the close of the accounting year." Further, the Company will not be publishing the un-audited financial results for the quarter ended December 31, 2008.
Oct 2008
24 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 45695 lacs for quarter ending on 30-SEP-2008 against Rs. 42080 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 13197 lacs for the quarter ending on 30-SEP-2008 against Rs. 24901 lacs for the quarter ending on 30-SEP-2007.13 Oct · Board meeting
Inter alia, to consider amongst other things, approval of unaudited financial results for the 3rd quarter ended September 30, 2008.
Jul 2008
28 Jul · Results
Standalone Results for the half year ended on 30-JUN-2008 as follows: Net Sales of Rs. 83501 lacs for half year ending on 30-JUN-2008 against Rs. 81707 lacs for the half year ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 23613 lacs for the half year ending on 30-JUN-2008 against Rs. 20775 lacs for the half year ending on 30-JUN-2007.28 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 41690 lacs for quarter ending on 30-JUN-2008 against Rs. 39561 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 11486 lacs for the quarter ending on 30-JUN-2008 against Rs. 9643 lacs for the quarter ending on 30-JUN-2007.9 Jul · Board meeting
Inter alia, to consider amongst other things, approval of unaudited financial results for the quarter April - June 2008 (Q2) and half-year January - June 2008.
May 2008
14 May · Business
Press release dated May 14, 2008, titled "GSK Pharma signs co-promotion agreement with Daiichi Sankyo for anti-hypertensive drug". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 May · Business
Press release dated May 05, 2008, titled "GSK Pharma signs licensing agreement with Astellas of Japan". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2008
21 Apr · Results
Standalone Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 41811 lacs for quarter ending on 31-MAR-2008 against Rs. 42146 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 12127 lacs for the quarter ending on 31-MAR-2008 against Rs. 11132 lacs for the quarter ending on 31-MAR-2007.1 Apr · Board meeting
Meeting on 21 Apr 2008: “Unaudited Financial Results for the qtr ended March 31, 2008”
Mar 2008
27 Mar · Meeting
Notice of the Annual General Meeting of the members to be held on April 21, 2008. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.
Feb 2008
25 Feb · Corporate action
Register of Members and the share transfer Books of the Company will be closed from April 04, 2008 to April 21, 2008 (both days inclusive) for the purpose of payment of Dividend. Further the dividend will be payable on or after April 21, 2008.